Conversely, NUDT5 sgRNAs were significantly enriched in B-ALL cells that survived thiopurine treatment (FC = 18.4 and 3.2, respectively, P = 0.002), indicating that NUDT5 deficiency drives drug resistance. The gene discussed is NUDT5; the disease is acute lymphoblastic leukemia.